| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 4.48e-05 | 17 | 12 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 4.48e-05 | 17 | 12 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | phospholipid binding | 2.33e-04 | 548 | 12 | 4 | GO:0005543 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 8.50e-04 | 73 | 12 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.68e-03 | 103 | 12 | 2 | GO:0004725 | |
| GeneOntologyMolecularFunction | lipid binding | 2.14e-03 | 988 | 12 | 4 | GO:0008289 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 2.35e-03 | 122 | 12 | 2 | GO:0072341 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.54e-03 | 127 | 12 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 5.53e-03 | 189 | 12 | 2 | GO:0004721 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.94e-05 | 18 | 11 | 2 | GO:1903385 | |
| Domain | PTPc | 2.36e-04 | 36 | 12 | 2 | SM00194 | |
| Domain | RA | 2.36e-04 | 36 | 12 | 2 | PF00788 | |
| Domain | RA | 2.49e-04 | 37 | 12 | 2 | PS50200 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.77e-04 | 39 | 12 | 2 | PS50055 | |
| Domain | RA_dom | 2.91e-04 | 40 | 12 | 2 | IPR000159 | |
| Domain | PTPase_domain | 3.06e-04 | 41 | 12 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 3.06e-04 | 41 | 12 | 2 | PF00102 | |
| Domain | Tyr_Pase_cat | 6.34e-04 | 59 | 12 | 2 | IPR003595 | |
| Domain | PTPc_motif | 6.34e-04 | 59 | 12 | 2 | SM00404 | |
| Domain | Tyr_Pase_AS | 9.70e-04 | 73 | 12 | 2 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 1.34e-03 | 86 | 12 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.37e-03 | 87 | 12 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.37e-03 | 87 | 12 | 2 | IPR000387 | |
| Domain | - | 1.53e-03 | 92 | 12 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.77e-03 | 99 | 12 | 2 | IPR029021 | |
| Domain | fn3 | 4.66e-03 | 162 | 12 | 2 | PF00041 | |
| Domain | FN3 | 6.03e-03 | 185 | 12 | 2 | SM00060 | |
| Domain | FN3 | 6.95e-03 | 199 | 12 | 2 | PS50853 | |
| Domain | FN3_dom | 7.64e-03 | 209 | 12 | 2 | IPR003961 | |
| Domain | PH | 9.11e-03 | 229 | 12 | 2 | PF00169 | |
| Domain | PH | 1.32e-02 | 278 | 12 | 2 | SM00233 | |
| Domain | PH_DOMAIN | 1.33e-02 | 279 | 12 | 2 | PS50003 | |
| Domain | PH_domain | 1.34e-02 | 280 | 12 | 2 | IPR001849 | |
| Domain | - | 2.51e-02 | 391 | 12 | 2 | 2.30.29.30 | |
| Pubmed | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. | 3.27e-07 | 3 | 12 | 2 | 29907679 | |
| Pubmed | 1.64e-06 | 6 | 12 | 2 | 21724833 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.51e-06 | 1489 | 12 | 6 | 28611215 | |
| Pubmed | 1.31e-05 | 16 | 12 | 2 | 18308476 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.48e-05 | 17 | 12 | 2 | 19727691 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 1.17e-04 | 47 | 12 | 2 | 19167335 | |
| Interaction | MRPS25 interactions | 1.41e-05 | 269 | 12 | 4 | int:MRPS25 | |
| Interaction | MRPS34 interactions | 2.69e-05 | 317 | 12 | 4 | int:MRPS34 | |
| Interaction | MRPS7 interactions | 4.19e-05 | 355 | 12 | 4 | int:MRPS7 | |
| Interaction | RPL39P5 interactions | 1.31e-04 | 29 | 12 | 2 | int:RPL39P5 | |
| Interaction | ZNF784 interactions | 1.50e-04 | 31 | 12 | 2 | int:ZNF784 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.02e-05 | 21 | 11 | 2 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 4.06e-03 | 160 | 11 | 2 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.64e-03 | 206 | 11 | 2 | 682 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.37e-05 | 181 | 12 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 190 | 12 | 3 | 6514f00d222eef08c282face7f177259bca62f0e | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.66e-05 | 193 | 12 | 3 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 194 | 12 | 3 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 194 | 12 | 3 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 194 | 12 | 3 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.69e-05 | 194 | 12 | 3 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 194 | 12 | 3 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 194 | 12 | 3 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.82e-05 | 199 | 12 | 3 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-04 | 125 | 12 | 2 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.04e-04 | 126 | 12 | 2 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 5.04e-04 | 126 | 12 | 2 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 5.04e-04 | 126 | 12 | 2 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 5.12e-04 | 127 | 12 | 2 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.28e-04 | 129 | 12 | 2 | 5578a9ef85706ab6a204ff31716e781ec3893b75 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-04 | 130 | 12 | 2 | 124f76067a2d4448ce06158a769d0d11b0297110 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-04 | 130 | 12 | 2 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | Control-Myeloid_G|Control / Disease group, lineage and cell class | 5.45e-04 | 131 | 12 | 2 | d5a53431f1f1b283fb9338b8561e6381f0227c62 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.87e-04 | 136 | 12 | 2 | 5e209185b5f6e9347829fc9066f0b2c3711df057 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.13e-04 | 139 | 12 | 2 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.39e-04 | 142 | 12 | 2 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.48e-04 | 143 | 12 | 2 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-04 | 151 | 12 | 2 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-04 | 153 | 12 | 2 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.71e-04 | 156 | 12 | 2 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | PBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 7.90e-04 | 158 | 12 | 2 | 5fefab4831687cd8dd45f5cc84f681398069c3be | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.10e-04 | 160 | 12 | 2 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-04 | 160 | 12 | 2 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-04 | 160 | 12 | 2 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 8.41e-04 | 163 | 12 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-04 | 164 | 12 | 2 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-04 | 164 | 12 | 2 | f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-04 | 165 | 12 | 2 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-04 | 165 | 12 | 2 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-04 | 166 | 12 | 2 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-04 | 166 | 12 | 2 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-04 | 166 | 12 | 2 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 8.82e-04 | 167 | 12 | 2 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 8.93e-04 | 168 | 12 | 2 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.93e-04 | 168 | 12 | 2 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 9.03e-04 | 169 | 12 | 2 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 169 | 12 | 2 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.03e-04 | 169 | 12 | 2 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 169 | 12 | 2 | f982f2e0d341fa27229f443ebe5c0e4a9e63bda6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.03e-04 | 169 | 12 | 2 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 9.14e-04 | 170 | 12 | 2 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 9.24e-04 | 171 | 12 | 2 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.24e-04 | 171 | 12 | 2 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.24e-04 | 171 | 12 | 2 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 9.24e-04 | 171 | 12 | 2 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.24e-04 | 171 | 12 | 2 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 9.24e-04 | 171 | 12 | 2 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 9.35e-04 | 172 | 12 | 2 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 9.35e-04 | 172 | 12 | 2 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | severe_influenza-B_memory|World / disease group, cell group and cell class (v2) | 9.35e-04 | 172 | 12 | 2 | 0ff38f9431cec73250c580a6010cb7891a3fe3f1 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 9.35e-04 | 172 | 12 | 2 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-04 | 173 | 12 | 2 | 69b404e92aad3e6dff67e75466f073f20a71f13f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-04 | 173 | 12 | 2 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 9.57e-04 | 174 | 12 | 2 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.68e-04 | 175 | 12 | 2 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | (00)_Basal-(2)_48hpi|(00)_Basal / shred by cell type and Timepoint | 9.79e-04 | 176 | 12 | 2 | 0f6770296d7fa453ffbf6ca6d5fdebc888f6eb60 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 9.79e-04 | 176 | 12 | 2 | 4be270f6bb7da4070f972aca403109751646d155 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.90e-04 | 177 | 12 | 2 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.90e-04 | 177 | 12 | 2 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.90e-04 | 177 | 12 | 2 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-03 | 178 | 12 | 2 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-03 | 178 | 12 | 2 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.01e-03 | 179 | 12 | 2 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-03 | 179 | 12 | 2 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.01e-03 | 179 | 12 | 2 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-03 | 179 | 12 | 2 | fce1ba53815145f6248d4e90aedca3dad84e33e4 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.01e-03 | 179 | 12 | 2 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.02e-03 | 180 | 12 | 2 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-03 | 180 | 12 | 2 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 180 | 12 | 2 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-03 | 181 | 12 | 2 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-03 | 182 | 12 | 2 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-03 | 182 | 12 | 2 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-03 | 182 | 12 | 2 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-03 | 182 | 12 | 2 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-03 | 182 | 12 | 2 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-03 | 182 | 12 | 2 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 183 | 12 | 2 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 183 | 12 | 2 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.06e-03 | 183 | 12 | 2 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.06e-03 | 183 | 12 | 2 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.07e-03 | 184 | 12 | 2 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-03 | 184 | 12 | 2 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.07e-03 | 184 | 12 | 2 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.07e-03 | 184 | 12 | 2 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-03 | 185 | 12 | 2 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.08e-03 | 185 | 12 | 2 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| Drug | Tyr-Phe | 2.66e-05 | 15 | 12 | 2 | CID003421919 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 2059_DN | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 2118_UP | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.37e-04 | 199 | 12 | 3 | 6217_UP | |
| Drug | meprobamate | 9.51e-04 | 88 | 12 | 2 | CID000004064 | |
| Drug | AC1L1K12 | 1.27e-03 | 102 | 12 | 2 | CID000005292 | |
| Drug | aspartate | 2.21e-03 | 518 | 12 | 3 | CID000000424 | |
| Drug | nickel | 2.65e-03 | 552 | 12 | 3 | CID000000934 | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 3.02e-03 | 158 | 12 | 2 | 2338_UP | |
| Drug | n-butoxyethanol | 3.06e-03 | 581 | 12 | 3 | ctd:C017096 | |
| Disease | influenza A (H1N1) | 5.56e-04 | 87 | 12 | 2 | EFO_1001488 | |
| Disease | Uterine leiomyoma | 6.08e-04 | 91 | 12 | 2 | HP_0000131 | |
| Disease | wellbeing measurement | 2.41e-03 | 692 | 12 | 3 | EFO_0007869 | |
| Disease | uterine fibroid | 2.86e-03 | 199 | 12 | 2 | EFO_0000731 | |
| Disease | metabolic syndrome | 2.89e-03 | 200 | 12 | 2 | EFO_0000195 | |
| Disease | post-traumatic stress disorder | 2.94e-03 | 202 | 12 | 2 | EFO_0001358 | |
| Disease | aspartate aminotransferase measurement | 5.13e-03 | 904 | 12 | 3 | EFO_0004736 | |
| Disease | serum gamma-glutamyl transferase measurement | 5.29e-03 | 914 | 12 | 3 | EFO_0004532 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 9.23e-03 | 364 | 12 | 2 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YINANYVDGYNKAKA | 906 | P23470 | |
| QYGLGCKYIYQKNGD | 1141 | Q8WZ64 | |
| KLGQEGKYRVYHNQY | 841 | Q12830 | |
| QLKNVRANYYGKYIA | 206 | Q9UJA3 | |
| HAYRYTNGQYVKQGK | 81 | Q5T1M5 | |
| GQAYRAYQNYIKKNG | 656 | P08473 | |
| GRYYGRGYKNQAAIQ | 1001 | Q9NZB2 | |
| FKYGVQLYKNYQQAQ | 336 | Q14451 | |
| YINANYIRGYSGKEK | 446 | Q15256 | |
| YLENGYNQNYGRKFV | 91 | Q02985 | |
| KIYNGDYYRQGRIAK | 696 | P30530 | |
| KYGYKLQVSAFLNGN | 341 | Q9BUZ4 | |
| GNSKMKACNNYQYGY | 96 | Q8IYB0 |